0
2022
Patient Registry Software Market

Patient Registry Software Market

by Registry type (Disease Registry, Health Service Registry, Product Registry), by Software type (Standalone, Integrated), by Functionality (Population Health Management, Health Information Exchange, Patient Care Management, Medical Research and Clinical Studies, Others), by End User (Hospitals, Government and third party organizations, Pharma, Biotech and Medical Device Companies, Others): Global Opportunity Analysis and Industry Forecast, 2022-2031

Report Code: A02490
Oct 2022 | Pages: 339
Tables: 176
Charts: 67
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Patient Registry Software Market Research, 2031

The global patient registry software market was valued at $993.3 million in 2021, and is projected to reach $2,508.27 million by 2031, growing at a CAGR of 9.7% from 2022 to 2031. A patient registry is a systematic collection of data about individuals who share a certain disease or condition. Patient registries software can be used to monitor outcomes and study best practices in care or treatment of patients. It may pursue a specific, focused research agenda, collecting data for a limited time to answer a specific research question (or questions), or may collect data on an indefinite basis to answer a variety of existing and emerging research questions. Patient registries are playing an increasingly important role in the health care system. Patient registries can be used for a variety of purposes, including monitoring outcomes, studying best practices, and investigating emerging trends. Although patient registries have been around for many years, the use of electronic health records has made it easier than ever to collect and analyze data. As a result, patient registries are expected to play an even more important role in the years to come. Patient registries have traditionally been researcher-generated. Research institutions, academic clinical institutions, or individual research teams establish a registry, using private or Federal funds, for the purpose of observational data collection that can be used for a specific research agenda. These registries may be organized and operated in a variety of forms and formats. They may be operated by a single institution or by a collaborative of multiple institutions or clinics. Researcher-generated patient registries currently exist for a wide range of chronic or rare conditions, including many forms of cancer, diabetes, cystic fibrosis, acute coronary syndrome, and arthritis.

The COVID-19 pandemic had a positive impact on the patient registry software industry owing to increased usage of patient registry software for tracking the patients information and vaccines supply information. In addition, the increase in the number of COVID-19 patients also helped the market increase the growth.

The growth of patient registry software market size is driven by increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in hospitals and research organizations.

Patient Registry Software Market

Furthermore, the increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries helps to increase the patient registry software market growth. However, concerns related to the lack of maintenance of important private data security and privacy of the data and dearth of skilled resources hinder the growth of patient registry software market size. Conversely, the patient registry software market opportunity includes the trend like increase in awareness regarding technologies.

Impact of COVID-19 Pandemic on Patient Registry Software Market

The COVID-19 pandemic affected the patient registry software industry in positive way, like various other medical internet of things (IoT) industries were affected. The rise in the number of COVID-19 patients gave rise to the challenges to the healthcare providers of providing vaccines and products to patients in paralleled manner. The healthcare providers were helped by the registry software to find how many health-related products and vaccines must be needed in a particular area. Moreover, the COVID-19 infection was more prone to the people suffering from chronic respiratory disease, hypertension, cardiovascular disease, diabetes mellitus, and cancer. The administration of COVID-19 medication to these population was harmful for their life. Hence, the healthcare providers took the help of patient registry software to analyze the patient’s condition, and give appropriate medicine to reduce the viral infection. According to the data of Health IT government, the COVID-19 patient registry software allows the number of cases to be managed uniquely across various agencies and organizations. Moreover, the software also supported in nationwide tracking and reporting of infections/immunization. The patient registry software also helped to aggregate the clinical data such as test results and status updates from hospitals, public health departments, labs and physician practices for reporting and tracking of the disease. The patient registry software was also used by the department of Office of the National Coordinator for Health Information Technology (ONC) and American Public Health Association (APHA) as part of the Pandemic Response Hackathon sponsored for studying the data of COVID-19 test results and status in 2020.

Patient Registry Software Market Segmentation

The patient registry software market is segmented into Registry type, Software type, Functionality and End User. On the basis of registry type, the market is divided into disease registry, health service registry and product registry. The disease registry segment is further segmented by type into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. On the basis of software type, the market is classified into standalone and integrated. On the basis of functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. On the basis of end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. Region wise, the market is studied across North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA).

Market By Registry Type Segment Review

By registry type, the market is classified into disease registry, health service registry and product registry. The disease registry segment is further segmented by type. By type, it is segmented into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. The disease registry segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to advantages that are offered by these software and increased adoption of patient registry software.

Patient Registry Software Market
By Registry Type

Your browser does not support the canvas element.

The disease registry segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Get more information on this report : Request Sample Pages

Market By Software Type Segment Review

By software type, the market is classified into standalone and integrated. The integrated segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to surge in number of integrated software system adopted in hospitals and rise in prevalence of chronic conditions. Moreover, rise in preference of the cardiovascular diseases and oncology also helps in growth of the patient registry software market share.

Patient Registry Software Market
By Software Type

Your browser does not support the canvas element.

The integrated segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Get more information on this report : Request Sample Pages

Market By Functionality Segment Review

By functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. The population health management segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to surge in demand for medical research and clinical studies related to various healthcare issues, which is mainly due to increase in the incidences of various diseases. Moreover, rise in number of hospitals visits also contributes toward growth of the market.

Patient Registry Software Market
By Functionality

Your browser does not support the canvas element.

The population health management segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Get more information on this report : Request Sample Pages

Market By End User Segment Review

By end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. The government and third party organizations segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to surge in number of pharmaceutical, biotechnology and medical device companies, which is mainly due to increase in demand of pharmaceutical and biotechnology products.

Patient Registry Software Market
By End User

Your browser does not support the canvas element.

The government and third party organizations segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Get more information on this report : Request Sample Pages

Market By Region Review

North America was the dominant region in 2021, and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of chronic diseases, and surge in number of treatment procedures performed in the region. However, Asia-Pacific is expected to witness highest CAGR of 11.3% during the patient registry software market forecast period, owing to presence of high populace countries such as India and China, which increases prevalence rate of chronic diseases, geriatric population, and number of pharmaceutical companies.

Patient Registry Software Market
By Region

2031
North America 
Europe
Asia-Pacific
LAMEA

North America was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient registry software market analysis from 2021 to 2031 to identify the prevailing patient registry software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient registry software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient registry software market trends, key players, market segments, application areas, and market growth strategies.

Patient Registry Software Market Report Highlights

Aspects Details
Market Size By 2031 USD 2.5 billion
Growth Rate CAGR of 9.7%
Forecast period 2021 - 2031
Report Pages 339
By Registry type
  • Disease Registry
    • Type
      • Cardiovascular Registry
      • Diabetes Registry
      • Cancer Registry
      • Rare Disease Registry
      • Others
  • Health Service Registry
  • Product Registry
    • Type
      • Medical device Registry
      • Drug Registry
By Software type
  • Standalone
  • Integrated
By Functionality
  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Medical Research and Clinical Studies
  • Others
By End User
  • Hospitals
  • Government and third party organizations
  • Pharma, Biotech and Medical Device Companies
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest Of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest Of LAMEA)
Key Market Players Optum, Inc., Open Text Corporation., Ordinal Data, Inc., Conduent, Inc., Premier, Inc., Elekta AB (pub), Dacima Software Inc., FIGmd, Inc., ImageTrend, Inc., IQVIA Holdings, McKesson Corporation

Analyst Review

The patient registries are organized systems that use observational methods to collect uniform data on a population defined by a particular disease, condition or exposure, and that is followed over time. Patient registries can play an important role in monitoring the safety of medicines.

North America was the dominant region in 2021, and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of chronic diseases, and surge in number of treatment procedures performed in the region. However, Asia-Pacific is expected to witness highest CAGR during the analysis period, owing to presence of high populace countries such as India and China, which increases prevalence rate of chronic disease like cardiovascular diseases

 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Low bargaining power of suppliers

      • 3.3.2. Low threat of new entrants

      • 3.3.3. Low threat of substitutes

      • 3.3.4. Low intensity of rivalry

      • 3.3.5. Low bargaining power of buyers

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in the usage of electronic health records (EHRs)
        • 3.4.1.2. Increase in prevalence of chronic diseases
        • 3.4.1.3. Increase in government support for healthcare

      • 3.4.2. Restraints

        • 3.4.2.1. Lack of skilled professionals

      • 3.4.3. Opportunities

        • 3.4.3.1. Increase in awareness regarding technologies

  • CHAPTER 4: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Disease Registry

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

      • 4.2.4. Disease Registry Patient Registry Software Market by Type

        • 4.2.4.1. Cardiovascular Registry Market size and forecast, by region
        • 4.2.4.2. Diabetes Registry Market size and forecast, by region
        • 4.2.4.3. Cancer Registry Market size and forecast, by region
        • 4.2.4.4. Rare Disease Registry Market size and forecast, by region
        • 4.2.4.5. Others Market size and forecast, by region
    • 4.3. Health Service Registry

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Product Registry

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

      • 4.4.4. Product Registry Patient Registry Software Market by Type

        • 4.4.4.1. Medical device Registry Market size and forecast, by region
        • 4.4.4.2. Drug Registry Market size and forecast, by region
  • CHAPTER 5: PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Standalone

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Integrated

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

  • CHAPTER 6: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Population Health Management

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Health Information Exchange

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Patient Care Management

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

    • 6.5. Medical Research and Clinical Studies

      • 6.5.1. Key market trends, growth factors and opportunities

      • 6.5.2. Market size and forecast, by region

      • 6.5.3. Market share analysis by country

    • 6.6. Others

      • 6.6.1. Key market trends, growth factors and opportunities

      • 6.6.2. Market size and forecast, by region

      • 6.6.3. Market share analysis by country

  • CHAPTER 7: PATIENT REGISTRY SOFTWARE MARKET, BY END USER

    • 7.1. Overview

      • 7.1.1. Market size and forecast

    • 7.2. Hospitals

      • 7.2.1. Key market trends, growth factors and opportunities

      • 7.2.2. Market size and forecast, by region

      • 7.2.3. Market share analysis by country

    • 7.3. Government and third party organizations

      • 7.3.1. Key market trends, growth factors and opportunities

      • 7.3.2. Market size and forecast, by region

      • 7.3.3. Market share analysis by country

    • 7.4. Pharma, Biotech and Medical Device Companies

      • 7.4.1. Key market trends, growth factors and opportunities

      • 7.4.2. Market size and forecast, by region

      • 7.4.3. Market share analysis by country

    • 7.5. Others

      • 7.5.1. Key market trends, growth factors and opportunities

      • 7.5.2. Market size and forecast, by region

      • 7.5.3. Market share analysis by country

  • CHAPTER 8: PATIENT REGISTRY SOFTWARE MARKET, BY REGION

    • 8.1. Overview

      • 8.1.1. Market size and forecast By Region

    • 8.2. North America

      • 8.2.1. Key market trends, growth factors and opportunities

      • 8.2.2. Market size and forecast, by Registry type

        • 8.2.2.1. North America Disease Registry Patient Registry Software Market by Type
        • 8.2.2.2. North America Product Registry Patient Registry Software Market by Type
      • 8.2.3. Market size and forecast, by Software type

      • 8.2.4. Market size and forecast, by Functionality

      • 8.2.5. Market size and forecast, by End User

      • 8.2.6. Market size and forecast, by country

        • 8.2.6.1. U.S.
          • 8.2.6.1.1. Market size and forecast, by Registry type
          • 8.2.6.1.2. Market size and forecast, by Software type
          • 8.2.6.1.3. Market size and forecast, by Functionality
          • 8.2.6.1.4. Market size and forecast, by End User
        • 8.2.6.2. Canada
          • 8.2.6.2.1. Market size and forecast, by Registry type
          • 8.2.6.2.2. Market size and forecast, by Software type
          • 8.2.6.2.3. Market size and forecast, by Functionality
          • 8.2.6.2.4. Market size and forecast, by End User
        • 8.2.6.3. Mexico
          • 8.2.6.3.1. Market size and forecast, by Registry type
          • 8.2.6.3.2. Market size and forecast, by Software type
          • 8.2.6.3.3. Market size and forecast, by Functionality
          • 8.2.6.3.4. Market size and forecast, by End User
    • 8.3. Europe

      • 8.3.1. Key market trends, growth factors and opportunities

      • 8.3.2. Market size and forecast, by Registry type

        • 8.3.2.1. Europe Disease Registry Patient Registry Software Market by Type
        • 8.3.2.2. Europe Product Registry Patient Registry Software Market by Type
      • 8.3.3. Market size and forecast, by Software type

      • 8.3.4. Market size and forecast, by Functionality

      • 8.3.5. Market size and forecast, by End User

      • 8.3.6. Market size and forecast, by country

        • 8.3.6.1. Germany
          • 8.3.6.1.1. Market size and forecast, by Registry type
          • 8.3.6.1.2. Market size and forecast, by Software type
          • 8.3.6.1.3. Market size and forecast, by Functionality
          • 8.3.6.1.4. Market size and forecast, by End User
        • 8.3.6.2. France
          • 8.3.6.2.1. Market size and forecast, by Registry type
          • 8.3.6.2.2. Market size and forecast, by Software type
          • 8.3.6.2.3. Market size and forecast, by Functionality
          • 8.3.6.2.4. Market size and forecast, by End User
        • 8.3.6.3. UK
          • 8.3.6.3.1. Market size and forecast, by Registry type
          • 8.3.6.3.2. Market size and forecast, by Software type
          • 8.3.6.3.3. Market size and forecast, by Functionality
          • 8.3.6.3.4. Market size and forecast, by End User
        • 8.3.6.4. Italy
          • 8.3.6.4.1. Market size and forecast, by Registry type
          • 8.3.6.4.2. Market size and forecast, by Software type
          • 8.3.6.4.3. Market size and forecast, by Functionality
          • 8.3.6.4.4. Market size and forecast, by End User
        • 8.3.6.5. Spain
          • 8.3.6.5.1. Market size and forecast, by Registry type
          • 8.3.6.5.2. Market size and forecast, by Software type
          • 8.3.6.5.3. Market size and forecast, by Functionality
          • 8.3.6.5.4. Market size and forecast, by End User
        • 8.3.6.6. Rest of Europe
          • 8.3.6.6.1. Market size and forecast, by Registry type
          • 8.3.6.6.2. Market size and forecast, by Software type
          • 8.3.6.6.3. Market size and forecast, by Functionality
          • 8.3.6.6.4. Market size and forecast, by End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key market trends, growth factors and opportunities

      • 8.4.2. Market size and forecast, by Registry type

        • 8.4.2.1. Asia-Pacific Disease Registry Patient Registry Software Market by Type
        • 8.4.2.2. Asia-Pacific Product Registry Patient Registry Software Market by Type
      • 8.4.3. Market size and forecast, by Software type

      • 8.4.4. Market size and forecast, by Functionality

      • 8.4.5. Market size and forecast, by End User

      • 8.4.6. Market size and forecast, by country

        • 8.4.6.1. Japan
          • 8.4.6.1.1. Market size and forecast, by Registry type
          • 8.4.6.1.2. Market size and forecast, by Software type
          • 8.4.6.1.3. Market size and forecast, by Functionality
          • 8.4.6.1.4. Market size and forecast, by End User
        • 8.4.6.2. China
          • 8.4.6.2.1. Market size and forecast, by Registry type
          • 8.4.6.2.2. Market size and forecast, by Software type
          • 8.4.6.2.3. Market size and forecast, by Functionality
          • 8.4.6.2.4. Market size and forecast, by End User
        • 8.4.6.3. Australia
          • 8.4.6.3.1. Market size and forecast, by Registry type
          • 8.4.6.3.2. Market size and forecast, by Software type
          • 8.4.6.3.3. Market size and forecast, by Functionality
          • 8.4.6.3.4. Market size and forecast, by End User
        • 8.4.6.4. India
          • 8.4.6.4.1. Market size and forecast, by Registry type
          • 8.4.6.4.2. Market size and forecast, by Software type
          • 8.4.6.4.3. Market size and forecast, by Functionality
          • 8.4.6.4.4. Market size and forecast, by End User
        • 8.4.6.5. South Korea
          • 8.4.6.5.1. Market size and forecast, by Registry type
          • 8.4.6.5.2. Market size and forecast, by Software type
          • 8.4.6.5.3. Market size and forecast, by Functionality
          • 8.4.6.5.4. Market size and forecast, by End User
        • 8.4.6.6. Rest of Asia-Pacific
          • 8.4.6.6.1. Market size and forecast, by Registry type
          • 8.4.6.6.2. Market size and forecast, by Software type
          • 8.4.6.6.3. Market size and forecast, by Functionality
          • 8.4.6.6.4. Market size and forecast, by End User
    • 8.5. LAMEA

      • 8.5.1. Key market trends, growth factors and opportunities

      • 8.5.2. Market size and forecast, by Registry type

        • 8.5.2.1. LAMEA Disease Registry Patient Registry Software Market by Type
        • 8.5.2.2. LAMEA Product Registry Patient Registry Software Market by Type
      • 8.5.3. Market size and forecast, by Software type

      • 8.5.4. Market size and forecast, by Functionality

      • 8.5.5. Market size and forecast, by End User

      • 8.5.6. Market size and forecast, by country

        • 8.5.6.1. Brazil
          • 8.5.6.1.1. Market size and forecast, by Registry type
          • 8.5.6.1.2. Market size and forecast, by Software type
          • 8.5.6.1.3. Market size and forecast, by Functionality
          • 8.5.6.1.4. Market size and forecast, by End User
        • 8.5.6.2. Saudi Arabia
          • 8.5.6.2.1. Market size and forecast, by Registry type
          • 8.5.6.2.2. Market size and forecast, by Software type
          • 8.5.6.2.3. Market size and forecast, by Functionality
          • 8.5.6.2.4. Market size and forecast, by End User
        • 8.5.6.3. South Africa
          • 8.5.6.3.1. Market size and forecast, by Registry type
          • 8.5.6.3.2. Market size and forecast, by Software type
          • 8.5.6.3.3. Market size and forecast, by Functionality
          • 8.5.6.3.4. Market size and forecast, by End User
        • 8.5.6.4. Rest of LAMEA
          • 8.5.6.4.1. Market size and forecast, by Registry type
          • 8.5.6.4.2. Market size and forecast, by Software type
          • 8.5.6.4.3. Market size and forecast, by Functionality
          • 8.5.6.4.4. Market size and forecast, by End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product Mapping of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top player positioning, 2021

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Conduent, Inc.

      • 10.1.1. Company overview

      • 10.1.2. Key Executives

      • 10.1.3. Company snapshot

      • 10.1.4. Operating business segments

      • 10.1.5. Product portfolio

    • 10.2. Dacima Software Inc.

      • 10.2.1. Company overview

      • 10.2.2. Key Executives

      • 10.2.3. Company snapshot

      • 10.2.4. Operating business segments

      • 10.2.5. Product portfolio

    • 10.3. Elekta AB (pub)

      • 10.3.1. Company overview

      • 10.3.2. Key Executives

      • 10.3.3. Company snapshot

      • 10.3.4. Operating business segments

      • 10.3.5. Product portfolio

    • 10.4. FIGmd, Inc.

      • 10.4.1. Company overview

      • 10.4.2. Key Executives

      • 10.4.3. Company snapshot

      • 10.4.4. Operating business segments

      • 10.4.5. Product portfolio

    • 10.5. ImageTrend, Inc.

      • 10.5.1. Company overview

      • 10.5.2. Key Executives

      • 10.5.3. Company snapshot

      • 10.5.4. Operating business segments

      • 10.5.5. Product portfolio

    • 10.6. IQVIA Holdings

      • 10.6.1. Company overview

      • 10.6.2. Key Executives

      • 10.6.3. Company snapshot

      • 10.6.4. Operating business segments

      • 10.6.5. Product portfolio

    • 10.7. McKesson Corporation

      • 10.7.1. Company overview

      • 10.7.2. Key Executives

      • 10.7.3. Company snapshot

      • 10.7.4. Operating business segments

      • 10.7.5. Product portfolio

      • 10.7.6. Business performance

    • 10.8. Open Text Corporation.

      • 10.8.1. Company overview

      • 10.8.2. Key Executives

      • 10.8.3. Company snapshot

      • 10.8.4. Operating business segments

      • 10.8.5. Product portfolio

      • 10.8.6. Business performance

    • 10.9. Optum, Inc.

      • 10.9.1. Company overview

      • 10.9.2. Key Executives

      • 10.9.3. Company snapshot

      • 10.9.4. Operating business segments

      • 10.9.5. Product portfolio

    • 10.10. Ordinal Data, Inc.

      • 10.10.1. Company overview

      • 10.10.2. Key Executives

      • 10.10.3. Company snapshot

      • 10.10.4. Operating business segments

      • 10.10.5. Product portfolio

    • 10.11. Premier, Inc.

      • 10.11.1. Company overview

      • 10.11.2. Key Executives

      • 10.11.3. Company snapshot

      • 10.11.4. Operating business segments

      • 10.11.5. Product portfolio

  • LIST OF TABLES

  • TABLE 01. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 02. PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. GLOBAL DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 04. PATIENT REGISTRY SOFTWARE MARKET FOR CARDIOVASCULAR REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 05. PATIENT REGISTRY SOFTWARE MARKET FOR DIABETES REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 06. PATIENT REGISTRY SOFTWARE MARKET FOR CANCER REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 07. PATIENT REGISTRY SOFTWARE MARKET FOR RARE DISEASE REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 08. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 09. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH SERVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. GLOBAL PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 12. PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL DEVICE REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. PATIENT REGISTRY SOFTWARE MARKET FOR DRUG REGISTRY, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 15. PATIENT REGISTRY SOFTWARE MARKET FOR STANDALONE, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. PATIENT REGISTRY SOFTWARE MARKET FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
    TABLE 17. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 18. PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
    TABLE 19. PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY REGION, 2021-2031 ($MILLION)
    TABLE 20. PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY REGION, 2021-2031 ($MILLION)
    TABLE 21. PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH AND CLINICAL STUDIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 22. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 23. GLOBAL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 24. PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 25. PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT AND THIRD PARTY ORGANIZATIONS, BY REGION, 2021-2031 ($MILLION)
    TABLE 26. PATIENT REGISTRY SOFTWARE MARKET FOR PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 27. PATIENT REGISTRY SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 28. PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 29. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 30. NORTH AMERICA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 31. NORTH AMERICA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 32. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 33. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 34. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 35. NORTH AMERICA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 36. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 37. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 38. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 39. U.S. PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 40. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 41. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 42. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 43. CANADA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 44. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 45. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 46. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 47. MEXICO PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 48. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 49. EUROPE DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 50. EUROPE PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 51. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 52. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 53. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 54. EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 55. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 56. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 57. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 58. GERMANY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 59. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 60. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 61. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 62. FRANCE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 63. UK PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 64. UK PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 65. UK PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 66. UK PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 67. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 68. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 69. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 70. ITALY PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 71. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 72. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 73. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 74. SPAIN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 75. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 76. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 77. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 78. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 79. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 80. ASIA-PACIFIC DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 81. ASIA-PACIFIC PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 82. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 83. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 84. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 85. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 86. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 87. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 88. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 89. JAPAN PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 90. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 91. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 92. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 93. CHINA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 94. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 95. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 96. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 97. AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 98. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 99. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 100. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 101. INDIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 102. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 103. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 104. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 105. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 106. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 107. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 108. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 109. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 110. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 111. LAMEA DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 112. LAMEA PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 113. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 114. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 115. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 116. LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 117. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 118. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 119. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 120. BRAZIL PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 121. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 122. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 123. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 124. SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 125. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 126. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 127. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 128. SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 129. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2021-2031 ($MILLION)
    TABLE 130. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE, 2021-2031 ($MILLION)
    TABLE 131. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2021-2031 ($MILLION)
    TABLE 132. REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 133. CONDUENT, INC.: KEY EXECUTIVES
    TABLE 134. CONDUENT, INC.: COMPANY SNAPSHOT
    TABLE 135. CONDUENT, INC.: PRODUCT SEGMENTS
    TABLE 136. CONDUENT, INC.: PRODUCT PORTFOLIO
    TABLE 137. DACIMA SOFTWARE INC.: KEY EXECUTIVES
    TABLE 138. DACIMA SOFTWARE INC.: COMPANY SNAPSHOT
    TABLE 139. DACIMA SOFTWARE INC.: PRODUCT SEGMENTS
    TABLE 140. DACIMA SOFTWARE INC.: PRODUCT PORTFOLIO
    TABLE 141. ELEKTA AB (PUB): KEY EXECUTIVES
    TABLE 142. ELEKTA AB (PUB): COMPANY SNAPSHOT
    TABLE 143. ELEKTA AB (PUB): PRODUCT SEGMENTS
    TABLE 144. ELEKTA AB (PUB): PRODUCT PORTFOLIO
    TABLE 145. FIGMD, INC.: KEY EXECUTIVES
    TABLE 146. FIGMD, INC.: COMPANY SNAPSHOT
    TABLE 147. FIGMD, INC.: PRODUCT SEGMENTS
    TABLE 148. FIGMD, INC.: PRODUCT PORTFOLIO
    TABLE 149. IMAGETREND, INC.: KEY EXECUTIVES
    TABLE 150. IMAGETREND, INC.: COMPANY SNAPSHOT
    TABLE 151. IMAGETREND, INC.: PRODUCT SEGMENTS
    TABLE 152. IMAGETREND, INC.: PRODUCT PORTFOLIO
    TABLE 153. IQVIA HOLDINGS: KEY EXECUTIVES
    TABLE 154. IQVIA HOLDINGS: COMPANY SNAPSHOT
    TABLE 155. IQVIA HOLDINGS: PRODUCT SEGMENTS
    TABLE 156. IQVIA HOLDINGS: PRODUCT PORTFOLIO
    TABLE 157. MCKESSON CORPORATION: KEY EXECUTIVES
    TABLE 158. MCKESSON CORPORATION: COMPANY SNAPSHOT
    TABLE 159. MCKESSON CORPORATION: SERVICE SEGMENTS
    TABLE 160. MCKESSON CORPORATION: PRODUCT PORTFOLIO
    TABLE 161. OPEN TEXT CORPORATION.: KEY EXECUTIVES
    TABLE 162. OPEN TEXT CORPORATION.: COMPANY SNAPSHOT
    TABLE 163. OPEN TEXT CORPORATION.: SERVICE SEGMENTS
    TABLE 164. OPEN TEXT CORPORATION.: PRODUCT PORTFOLIO
    TABLE 165. OPTUM, INC.: KEY EXECUTIVES
    TABLE 166. OPTUM, INC.: COMPANY SNAPSHOT
    TABLE 167. OPTUM, INC.: PRODUCT SEGMENTS
    TABLE 168. OPTUM, INC.: PRODUCT PORTFOLIO
    TABLE 169. ORDINAL DATA, INC.: KEY EXECUTIVES
    TABLE 170. ORDINAL DATA, INC.: COMPANY SNAPSHOT
    TABLE 171. ORDINAL DATA, INC.: PRODUCT SEGMENTS
    TABLE 172. ORDINAL DATA, INC.: PRODUCT PORTFOLIO
    TABLE 173. PREMIER, INC.: KEY EXECUTIVES
    TABLE 174. PREMIER, INC.: COMPANY SNAPSHOT
    TABLE 175. PREMIER, INC.: PRODUCT SEGMENTS
    TABLE 176. PREMIER, INC.: PRODUCT PORTFOLIO
  • LIST OF FIGURES

  • FIGURE 1.PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION
    FIGURE 2.PATIENT REGISTRY SOFTWARE MARKET,2021-2031
    FIGURE 3.PATIENT REGISTRY SOFTWARE MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.PATIENT REGISTRY SOFTWARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.PATIENT REGISTRY SOFTWARE MARKET,BY REGISTRY TYPE,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DISEASE REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF HEALTH SERVICE REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PRODUCT REGISTRY PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 16.PATIENT REGISTRY SOFTWARE MARKET,BY SOFTWARE TYPE,2021(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF STANDALONE PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF INTEGRATED PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 19.PATIENT REGISTRY SOFTWARE MARKET,BY FUNCTIONALITY,2021(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF POPULATION HEALTH MANAGEMENT PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HEALTH INFORMATION EXCHANGE PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PATIENT CARE MANAGEMENT PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF MEDICAL RESEARCH AND CLINICAL STUDIES PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 25.PATIENT REGISTRY SOFTWARE MARKET,BY END USER,2021(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 27.COMPARATIVE SHARE ANALYSIS OF GOVERNMENT AND THIRD PARTY ORGANIZATIONS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 28.COMPARATIVE SHARE ANALYSIS OF PHARMA, BIOTECH AND MEDICAL DEVICE COMPANIES PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 29.COMPARATIVE SHARE ANALYSIS OF OTHERS PATIENT REGISTRY SOFTWARE MARKET,2021-2031(%)
    FIGURE 30.PATIENT REGISTRY SOFTWARE MARKET BY REGION,2021
    FIGURE 31.U.S. PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 32.CANADA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 33.MEXICO PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 34.GERMANY PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 35.FRANCE PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 36.UK PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 37.ITALY PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 38.SPAIN PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 39.REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 40.JAPAN PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 41.CHINA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 42.AUSTRALIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 43.INDIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 44.SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 45.REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 46.BRAZIL PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 47.SAUDI ARABIA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 48.SOUTH AFRICA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 49.REST OF LAMEA PATIENT REGISTRY SOFTWARE MARKET,2021-2031($MILLION)
    FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 53.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 54.COMPETITIVE DASHBOARD
    FIGURE 55.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 56.CONDUENT, INC..: NET SALES ,($MILLION)
    FIGURE 57.DACIMA SOFTWARE INC..: NET SALES ,($MILLION)
    FIGURE 58.ELEKTA AB (PUB).: NET SALES ,($MILLION)
    FIGURE 59.FIGMD, INC..: NET SALES ,($MILLION)
    FIGURE 60.IBM CORP.: NET SALES ,($MILLION)
    FIGURE 61.IMAGETREND, INC..: NET SALES ,($MILLION)
    FIGURE 62.IQVIA HOLDINGS.: NET SALES ,($MILLION)
    FIGURE 63.MCKESSON CORPORATION.: NET SALES ,($MILLION)
    FIGURE 64.OPENTEXT CORPORATION.: NET SALES ,($MILLION)
    FIGURE 65.OPTUM, INC..: NET SALES ,($MILLION)
    FIGURE 66.ORDINAL DATA, INC..: NET SALES ,($MILLION)
    FIGURE 67.PREMIER, INC..: NET SALES ,($MILLION)

 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The key trends of Patient Registry Software Market include the increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in hospitals and research organizations.

A. The leading application of patient registry software market is that the patient registry software helps deliver insights from a multi-terabyte database anywhere, anytime, and on any platform, with ease of management.

A. North America is the largest regional market for patient registry software market.

A. The estimated industry size of patient registry software market in 2031 is $2,508.27 million.

A. The top companies to hold the market share in patient registry software Market include Allscripts healthcare solutions, Inc., Elekta Solutions AB, IQVIA Holdings Inc., McKesson Corporation, MRO Corp. (FIGmd, Inc.), Open Text Corporation.

A. The forecast period in the market report is from 2022 to 2031.

A. Yes, the patient registry software market report provides PORTER Analysis.

A. Yes, the patient registry software market companies are profiled in the report.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Patient Registry Software Market

Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2023 - Oct 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers